Journalists working on stories related to high-risk pregnancies or the Society for Maternal-Fetal Medicine can contact Greg Phillips, Director of Communications, at press@smfm.org for referrals to MFM experts and to request additional information. The press office is open Monday through Friday from 9:00 AM to 5:00 PM ET.
The Society for Maternal-Fetal Medicine is pleased to announce this year’s awards presented at the SMFM 2026 Pregnancy Meeting™ in Las Vegas, NV. Continue Reading
The Society for Maternal-Fetal Medicine (SMFM) is pleased to announce Alison G. Cahill, MD, MSCI, from the University of Texas at Austin Dell Medical School, as its new president for 2026-2027. Dr. Cahill will assume the SMFM presidency today at the conclusion of the 2026 Pregnancy Meeting™. Continue Reading
First-time mothers who were randomized to receive a smartphone app called Baby2Home for the first year after giving birth reported significantly fewer symptoms of stress, depression, and anxiety, as well as better overall health, compared to first-time mothers who received usual postpartum care. Continue Reading
In just a few weeks, SMFM will welcome experts, researchers, students, and healthcare professionals in obstetrics Marvin Williams, DOPoster Chair to the 2026 Pregnancy Meeting in Las Vegas, Nevada. I am proud to share that we have an impressive research lineup! As Dr. Allison Bryant shared... Continue Reading
The Society for Maternal-Fetal Medicine (SMFM) is pleased to announce that Jerasimos Ballas, MD, MPH; Catherine S. Eppes, MD, MPH; Moeun Son, MD, MSCI; and Sarahn M. Wheeler, MD, MHSc, have been elected to the SMFM Board. Continue Reading
Prepregnancy counseling, assembling multidisciplinary care teams, and referring to centers with expertise are critical in managing pregnant patients with heart failure to optimize maternal and newborn health outcomes, according to new guidance issued by SMFM. Continue Reading
The Society for Maternal-Fetal Medicine (SMFM) and the Society of OB/GYN Hospitalists (SOGH) are pleased to announce a focused commitment to our partnership that prioritizes the advancement of hospital-based obstetric care across the United States. Continue Reading
By: Adam K. Lewkowitz, MD, MPHS, and Emily S. Miller, MD, MPH On July 21, 2025, the Food and Drug Administration (FDA) convened a roundtable panelist discussion on the use of selective serotonin reuptake inhibitors (SSRIs), a class of antidepressant medication, in pregnancy. The FDA... Continue Reading
By Brian K. Iriye, MD; Vanita D. Jain, MD; and Anthony C. Sciscione, DO What is DFTU and Why Is It Important? The Detailed First-Trimester Ultrasound (DFTU) is a high-resolution scan performed between weeks 12 and 13 of pregnancy to detect fetal structural anomalies.1 It is indicated for... Continue Reading
The Society for Maternal-Fetal Medicine (SMFM) is deeply disappointed in today’s final vote by the House of Representatives resulting in the passage of H.R. 1. The deep cuts to the Medicaid program contained in this legislation jeopardize the insurance coverage millions of... Continue Reading
SMFM urges members of the House of Representatives to reject H.R. 1 in its current form and, instead, pursue legislation that preserves and expands access to high-quality pregnancy care for all Americans. Continue Reading
More than 30 organizations representing millions of patients with serious health conditions and thousands of medical professionals are applauding the protection of access to lifesaving preventive care without patient cost sharing. Continue Reading
